Correlation Study of Four HER2 Immunohistochemical Staining Assays in Breast Cancer and Changes of Heterogeneity Patterns

被引：0
|
作者：
Yue, Meng [1 ]
Wu, Si [1 ]
Huang, Liujing
Lei, Ming
Liu, Hongbo [1 ]
Wei, Weiwei
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
264
引用
收藏
页码：S322 / S324
页数：3
相关论文
共 50 条
  • [31] Validation of a fully automated HER2 staining kit in breast cancer
    Moelans, Cathy B.
    Kibbelaar, Robby E.
    van den Heuvel, Marius C.
    Castigliego, Domenico
    de Weger, Roel A.
    van Diest, Paul J.
    CELLULAR ONCOLOGY, 2010, 32 (1-2) : 149 - 155
  • [32] HER2 staining intensity has prognostic impact on patients with HER2 type invasive breast cancer
    Yi-Hsuan, H.
    Yen-Shu, L.
    Chih-Yi, H.
    Ling-Ming, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [33] Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
    Sun, Hongxia
    Kang, Eun Young
    Chen, Hui
    Sweeney, Keith J.
    Suchko, Michael
    Wu, Yun
    Wen, Jianguo
    Krishnamurthy, Savitri
    Albarracin, Constance T.
    Ding, Qing-Qing
    Foo, Wai Chin
    Sahin, Aysegul A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (02) : 403 - 411
  • [34] Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis
    Hongxia Sun
    Eun Young Kang
    Hui Chen
    Keith J. Sweeney
    Michael Suchko
    Yun Wu
    Jianguo Wen
    Savitri Krishnamurthy
    Constance T. Albarracin
    Qing-Qing Ding
    Wai Chin Foo
    Aysegul A. Sahin
    Breast Cancer Research and Treatment, 2024, 205 : 403 - 411
  • [35] A study on the prevalence of HER2 genetic heterogeneity and its impact on breast cancer survival
    Ho, Jingshan
    Chan, Daniel Boon Yeow
    Lee, Soo-Chin
    Koay, Evelyn S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Study of HER2 in Breast Cancer Disease
    Mhmood, Baraa R.
    Allwsh, Thikra A.
    EGYPTIAN JOURNAL OF CHEMISTRY, 2021, 64 (12): : 7007 - 7012
  • [37] Institutional Quality Assurance for Breast Cancer HER2 Immunohistochemical Testing: Identification of Outlier Practice Patterns
    Green, I. F.
    Zynger, D. L.
    MODERN PATHOLOGY, 2014, 27 : 51A - 52A
  • [38] Institutional Quality Assurance for Breast Cancer HER2 Immunohistochemical Testing: Identification of Outlier Practice Patterns
    Green, I. F.
    Zynger, D. L.
    LABORATORY INVESTIGATION, 2014, 94 : 51A - 52A
  • [39] Immunohistochemical Profile of Breast Cancer with Respect to ER and HER2 Status
    Gloyeske, N. C.
    Yu, J.
    Elishaev, E.
    Woodard, A. H.
    Dabbs, D. J.
    Bhargava, R.
    MODERN PATHOLOGY, 2013, 26 : 44A - 44A
  • [40] Immunohistochemical Profile of Breast Cancer with Respect to ER and HER2 Status
    Gloyeske, N. C.
    Yu, J.
    Elishaev, E.
    Woodard, A. H.
    Dabbs, D. J.
    Bhargava, R.
    LABORATORY INVESTIGATION, 2013, 93 : 44A - 44A
12345